GenEdit Inc

GenEdit Inc

GenEdit Inc

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Founded
2016
Raised
$34.5M
Follow us
Alexa global traffic share
Twitter followers
11 Dec 2018
$8,500,000
Seed fund

GenEdit Closes $8.5 Million Series Seed Financing

StartupWorld
+2